Skip to main content
. 2024 Jun 8;17(6):1259–1264. doi: 10.14202/vetworld.2024.1259-1264

Table-3.

The checkerboard results of the effect of combinations of the peptide KW-23 with the antibiotics used in the study against the both bacterial strains used.

Bacteria strains Antibiotics MIC FICI*

Antibiotics Antibiotics/KW-23 KW-23 KW-23/antibiotics
Control P. aeruginosa Levofloxacin 9 2 4.5 1.5 0.6
Chloramphenicol 80 15 4.5 2 0.63
Rifampicin 15 3 4.5 0.5 0.3
Amoxicillin 25 10 4.5 0.25 0.45
Clarithromycin 125 65 4.5 2 0.96
Doxycycline 6 2 4.5 0.125 0.36
Vancomycin 200 175 4.5 3.5 1.65
Cefixime 6 0.5 4.5 1 0.3
Gentamicin 2 0.125 4.5 0.025 0.07
MDR P. aeruginosa Levofloxacin 30 15 20 10 1
Chloramphenicol 150 60 20 15 1.15
Rifampicin 50 20 20 5 0.65
Amoxicillin 200 120 20 18 1.5
Clarithromycin 125 80 20 5 0.9
Doxycycline 34 10 20 2 0.4
Vancomycin 260 150 20 15 1.3
Cefixime 82 40 20 12 1.08
Gentamicin 20 5 20 0.5 0.27

Synergistic (FIC ≤ 0.5), additive (FIC 0.5 < FIC ≤ 1), indifferent (1 < FIC ≤ 4), or antagonist (FIC > 4). FICI=Fractional inhibitory concentration index, P. aeruginosa=Pseudomonas aeruginosa, MIC=Minimum inhibitory concentration, MDR=Multidrug resistant